Article Sidebar
Published:
Aug 29, 2006Article Details
Issue
Section
Articles
Material submitted for publication in the South African Journal of Clinical Nutrition (SAJCN) is accepted provided it has not been published elsewhere. Copyright forms will be sent with acknowledgement of receipt and the SAJCN reserves copyright of the material published.
The SAJCN does not hold itself responsible for statements made by the authors.
Main Article Content
Association between vitamin A and E and apolipoprotein A and B levels in type 2 diabetes
Abstract
Objective. To determine the relationship between serum vitamin A and E and apolipoprotein levels in type 2 diabetic patients.
Setting. Shariati Hospital, Tehran, Iran.
Subjects and methods. One hundred and seventeen eligible type 2 diabetic patients who attended the Endocrine Research and Metabolism Center between 2002 and 2004 were enrolled in the study. Blood samples were collected after a 12 - 14-hour overnight fast for the measurement of serum levels of total cholesterol, triglyceride, high-density lipoprotein (HDL), low-density lipoprotein (LDL), apolipoprotein (apo) A1 and apoB, and vitamins A and E. Anthropometric indices were determined by physical examination. Data were analysed statistically using Pearson's coefficient, multiple regression, and partial and bivariate correlations.
Results. The mean body mass index (BMI) of the subjects was 27.4 ± 3.7 kg/m2. The mean (± standard deviation (SD)) serum levels of vitamins A and E were 0.5 ± 0.1 μg/ml and 9.5 ± 2.6 μg/ml, respectively. There were no significant differences in the plasma levels of vitamins A and E in males and females. Mean serum levels of vitamins A and E were within the normal range for both sexes. Serum lipid levels (total cholesterol, triglyceride and apoB) correlated with serum levels of vitamin E (p < 0.05). Serum levels of vitamins A and E were also correlated (p < 0.05). Standardised vitamin E levels showed significant negative correlation with most studied lipid profiles (p < 0.05).
Conclusion. This study found that mean serum levels of the natural antioxidants vitamin E, and especially vitamin A, were close to the lower end of the normal range of these antioxidants in type 2 diabetics. Also, serum vitamin E and standardised vitamin E levels were important predictors of serum apoA1 levels in these patients.
South African Journal of Clinical Nutrition Vol. 19(1) 2006: 39-44
Setting. Shariati Hospital, Tehran, Iran.
Subjects and methods. One hundred and seventeen eligible type 2 diabetic patients who attended the Endocrine Research and Metabolism Center between 2002 and 2004 were enrolled in the study. Blood samples were collected after a 12 - 14-hour overnight fast for the measurement of serum levels of total cholesterol, triglyceride, high-density lipoprotein (HDL), low-density lipoprotein (LDL), apolipoprotein (apo) A1 and apoB, and vitamins A and E. Anthropometric indices were determined by physical examination. Data were analysed statistically using Pearson's coefficient, multiple regression, and partial and bivariate correlations.
Results. The mean body mass index (BMI) of the subjects was 27.4 ± 3.7 kg/m2. The mean (± standard deviation (SD)) serum levels of vitamins A and E were 0.5 ± 0.1 μg/ml and 9.5 ± 2.6 μg/ml, respectively. There were no significant differences in the plasma levels of vitamins A and E in males and females. Mean serum levels of vitamins A and E were within the normal range for both sexes. Serum lipid levels (total cholesterol, triglyceride and apoB) correlated with serum levels of vitamin E (p < 0.05). Serum levels of vitamins A and E were also correlated (p < 0.05). Standardised vitamin E levels showed significant negative correlation with most studied lipid profiles (p < 0.05).
Conclusion. This study found that mean serum levels of the natural antioxidants vitamin E, and especially vitamin A, were close to the lower end of the normal range of these antioxidants in type 2 diabetics. Also, serum vitamin E and standardised vitamin E levels were important predictors of serum apoA1 levels in these patients.
South African Journal of Clinical Nutrition Vol. 19(1) 2006: 39-44
